Statement of Ownership (sc 13g)
February 14 2022 - 4:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Brainstorm Cell Therapeutics Inc.
(Name of Issuer)
Common Stock, $0.00005 par value per share
(Title of Class of Securities)
10501E201
(CUSIP Number)
Jared Kelly, Esq.
Lowenstein Sandler LLP
1251 Avenue of the Americas
New York 10020
(212) 262-6700
(Name, Address and Telephone
Number of Person Authorized to Receive Notices and Communications)
February 14, 2022
(Date of Event which Requires Filing of this
Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
The information required on the remainder of this
cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP No. 10501E201
1.
|
|
NAMES OF REPORTING PERSONS
Abbhi Investments, LLC
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a) ¨
(b) ¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5.
|
|
SOLE VOTING POWER
2,425,853*
|
|
6.
|
|
SHARED VOTING POWER
0
|
|
7.
|
|
SOLE DISPOSITIVE POWER
2,425,853*
|
|
8.
|
|
SHARED DISPOSITIVE POWER
0
|
9.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,425,853*
|
10.
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions)
¨
|
11.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.69%
|
12.
|
|
TYPE OF REPORTING PERSON (see instructions)
OO
|
* Includes 250,000 shares of common stock issuable
upon the exercise of warrants, which are exercisable within 60 days at an exercise price of $15.00.
CUSIP No. 10501E201
1.
|
|
NAMES OF REPORTING PERSONS
Sankesh Abbhi (1)
|
2.
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a) o
(b) o
|
3.
|
|
SEC USE ONLY
|
4.
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Florida
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5.
|
|
SOLE VOTING POWER
2,425,853*
|
|
6.
|
|
SHARED VOTING POWER
0
|
|
7.
|
|
SOLE DISPOSITIVE POWER
2,425,853*
|
|
8.
|
|
SHARED DISPOSITIVE POWER
0
|
9.
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,425,853*
|
10.
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions)
o
|
11.
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.69%
|
12.
|
|
TYPE OF REPORTING PERSON (see instructions)
IN
|
* Includes 250,000 shares of common stock issuable upon the exercise
of warrants, which are exercisable within 60 days at an exercise price of $15.00.
(1) As the manager of Abbhi Investments, LLC who maintains sole
voting and investment power with respect to the common stock held by Abbhi Investments, LLC.
Explanatory
Note
This
Schedule 13G is filed to report the Reporting Persons’ beneficial ownership of 2,425,853 shares of common stock, $0.00005 par value
per share of Brainstorm Cell Therapeutics Inc. (the “common stock”), which includes 250,000 shares of common stock issuable
upon the exercise of warrants that are exercisable within 60 days at an exercise price of $15.00. The Reporting Persons’ current
beneficial ownership of the common stock is set forth on the cover pages hereto.
Item
1.
|
(a)
|
Name
of Issuer:
|
|
|
|
|
|
|
|
Brainstorm
Cell Therapeutics Inc. (the “Issuer”)
|
|
|
|
|
|
|
(b)
|
Address
of Issuer’s Principal Executive Offices:
|
|
|
|
|
|
|
|
1325 Avenue of Americas,
28th Floor
New York, New York 10019
|
|
|
|
|
Item
2.
|
(a) through
(c):
|
|
|
|
|
|
This
Schedule 13G is being filed by and on behalf of Abbhi Investments, LLC and Mr. Sankesh Abbhi (collectively, the “Reporting
Persons”). Abbhi Investments, LLC is the record owner of the common stock set forth on the cover pages hereto. Mr. Sankesh
Abbhi is the manager of Abbhi Investments, LLC and maintains sole voting and investment power with respect to the common stock held
by Abbhi Investments, LLC.
|
|
|
|
|
|
|
(a)-(c)
|
Name,
Address and Citizenship of Reporting Persons
|
|
|
|
Reporting
Person: Abbhi Investments, LLC
|
|
|
|
Address:
3119 Ponce de Leon Blvd, Unit C Coral Gables, FL 33134
|
|
|
|
Place of Organization: Florida
|
|
|
|
Reporting Person: Mr. Sankesh Abbhi
Address: 3119 Ponce de Leon Blvd, Unit C Coral Gables, FL 33134
Place of Residence: Florida
|
|
|
|
|
|
|
(d)
|
Title
of Class of Securities
|
|
|
|
|
|
|
|
Common
Stock, $0.00005 par value per share.
|
|
|
|
|
|
|
(e)
|
CUSIP
Number
|
|
|
|
|
|
|
|
10501E201
|
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is
a:
|
|
|
|
|
|
|
|
(a)
|
¨
|
Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
|
|
(b)
|
¨
|
Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
|
(c)
|
¨
|
Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
|
(d)
|
¨
|
Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
|
|
(e)
|
¨
|
An
investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
|
|
(f)
|
¨
|
An
employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
|
|
(g)
|
¨
|
A
parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
|
(h)
|
¨
|
A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
(i)
|
¨
|
A
church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3);
|
|
|
|
|
|
(j)
|
¨
|
Group,
in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
|
|
Item 4.
|
Ownership.
|
|
|
|
Reference
is made as to the Reporting Persons’ ownership hereunder to the cover pages of this Schedule 13G, which is incorporated by
reference herein. The percentages used herein are calculated based upon 36,277,953 shares of
common stock outstanding as of November 15, 2021, as reported by the Issuer in its Form 10-Q
filed with the SEC on November 15, 2021.
|
Item 5.
|
Ownership of
Five Percent or Less of a Class.
|
|
|
|
Not
applicable.
|
Item 6.
|
Ownership of
More than Five Percent on Behalf of Another Person.
|
|
|
|
Not
applicable.
|
Item 7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
|
|
|
|
Not
applicable.
|
Item 8.
|
Identification
and Classification of Members of the Group.
|
|
|
|
Not
applicable.
|
Item 9.
|
Notice of Dissolution
of Group.
|
|
|
|
Not applicable.
|
Item 10.
|
Certification.
|
|
|
|
By signing below
I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with
a nomination under § 240.14a-11.
|
SIGNATURES
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: February 14, 2022
|
ABBHI
INVESTMENTS, LLC
|
|
|
|
|
/s/
Sankesh Abbhi
|
|
Name:
|
Sankesh Abbhi
|
|
Title:
|
Manager
|
|
|
|
|
SANKESH
ABBHI
|
|
|
|
|
/s/
Sankesh Abbhi
|
|
Name:
|
Sankesh Abbhi
|
Exhibit Index
Brainstorm Cell Therapeu... (NASDAQ:BCLI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Brainstorm Cell Therapeu... (NASDAQ:BCLI)
Historical Stock Chart
From Sep 2023 to Sep 2024